Posted by Michael Wonder on 19 May 2020
Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market
19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to critically needed medication for Canadian patients.
Teva Canada announced today it has secured an emergency supply of PrSalamol CFC-Free inhaler - 100 mcg pressurised inhalation suspension (salbutamol sulphate) 200 dose through its global supply chain (Teva UK) to alleviate critical shortages in the Canadian market.
Teva Canada is the first company to import this product for Canadian patients under an Interim Order signed by the Minister of Health
